A recent study looked at the role of the cerebellum and brainstem in migraine pain.
A study investigating the association with the cerebellum and pain and migraine found that the microstructural changes in the cerebellum and local brainstem of migraineurs without aura (MWoAs) could contribute to the dysfunction of the transmission of noxious information.
The study, published by The Journal of Headache and Pain, used the method of voxel-based morphometry and diffusion tensor imaging in order to evaluate the cerebellum and brainstem anatomical alterations associated with MWoAs. Additionally, the researchers used a spatially unbiased infratentorial template toolbox (SUIT) to perform cerebellum and brainstem optimized analyses.
Patients for the study were recruited from the outpatient clinic of the Department of Neurology at Shanghai Ninth People’s Hospital and were diagnosed with migraine without aura. Demographic and clinical data was collected, and patients completed the Migraine Disability Assessment Scale in order to obtain an accurate assessment of their headache-related disability.
“In the past decade, increasing evidence has suggested that the cerebellum is associated with pain and migraine. The cerebellum is a highly-organized brain area located in the hindbrain dorsal to the brainstem, which has been proposed to be related to the processing of sensorimotor, affective and cognitive information,” noted the authors. “Recent studies also demonstrated the involvement of the cerebellum in human nociception, and even suggest a modulating role in pain perception.
Following the analysis, MWoAs demonstrated decreased fractional anisotropy in the vermis VI extending to the bilateral lobules V and VI of the cerebellum. Additionally, higher axial diffusivity (AD), mean diffusivity (MD), and radial diffusivity (RD) was found in the right inferior cerebellum peduncle tract in MWoAs. Also, the researchers noted that MWoAs exhibited both reduced gray matter volume and increased AD, MD, and RD in the spinal trigeminal nucleus.
“MWoAs exhibited microstructural changes in the cerebellum and the local brainstem. These structural differences might contribute to dysfunction of the transmission and modulation of noxious information, trigeminal nociception, and conduction and integration of multimodal information in MWoAs,” concluded the authors. “These findings further suggest involvement of the cerebellum and the brainstem in the pathology of migraine without aura.”
The study suggest that future studies must evaluate the structural abnormalities of the brainstem and cerebellar areas of migraineurs with aura as well as chronic migraineurs during the ictal phase.
Reference
Qin Z, He X, Zhang J, et al. Structural changes of cerebellum and brainstem in migraine without aura [published online September 2, 2019]. The Journal of Headache and Pain. doi.org/10.1186/s10194-019-1045-5
Incorporating Discussions of Cannabis Use Into Oncology Care Visits
September 15th 2024The legalization of recreational marijuana in Minnesota has created daily conversations about how to incorporate the use of cannabis into treatment plans for patients with cancer, explained Marie Parish, PharmD, BCOP, of Mayo Clinic.
Read More
Update on Migraine Patient Care Challenges During the Pandemic
October 5th 2021Migraines plague some 35 million Americans, the majority of them women in their 30s and 40s, and disabling pain and symptoms are linked to lost productivity at work, school, and home. On this episode of Managed Care Cast, we bring you an excerpt of an interview with a headache specialist about the extra challenges for patients and providers during the pandemic.
Listen
Prior Authorization Requirements for Calcitonin Gene-Related Peptide Antagonists
April 20th 2023This quantitative and qualitative analysis highlights differences in prior authorization requirements for migraine drugs from nearly 50 managed care organizations and summarizes broad types of criteria used.
Read More
How Can Digital Care Programs Aid Those With Chronic Musculoskeletal Pain?
June 9th 2020On this episode of Managed Care Cast, we speak with Jeffrey Krauss, MD, chief medical officer of Hinge Health and Stanford Clinical assistant professor, about the efficacy of a 12-week digital care program aimed to reduce lower back and knee pain in a real-world population.
Listen
Care for Migraine Insufficient in Germany, Online Survey Finds
March 25th 2022An online survey of migraineurs in Germany aimed to evaluate their most pressing unmet needs, with data collected on socioeconomic background, medical care experience, acute medication use, and migraine prophylaxis use and experience.
Read More